Skip to main content
. 2023 Apr 19;14:1155104. doi: 10.3389/fimmu.2023.1155104

Figure 1.

Figure 1

PRISMA flow diagram of study selection. ASCO, American Society of Clinical Oncology; ESMO, European Society for Medical Oncology; HR, hazard ratio; RAASIs, renin-angiotensin-aldosterone system inhibitors.